PRME has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
PRME has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Cash Payments only applicable to companies reporting Cash Flow from Operations in direct method.
Robert Nelsen | director, 10 percent owner | 8755 W. HIGGINS ROAD, SUITE 1025, CHICAGO IL 60631 |
Arch Venture Partners X, Llc | 10 percent owner | 8755 W. HIGGINS ROAD, SUITE 1025, CHICAGO IL 60631 |
Gv 2019 Gp, L.l.c. | 10 percent owner | 1600 AMPHITHEATRE PKWY, MOUNTAIN VIEW CA 94043 |
Jeffrey D Marrazzo | director | 3737 MARKET STREET, SUITE 1300, PHILADELPHIA PA 19104 |
2019, L.p. Gv | 10 percent owner | 1600 AMPHITHEATRE PKWY, MOUNTAIN VIEW CA 94043 |
Alphabet Inc. | 10 percent owner | 1600 AMPHITHEATRE PARKWAY, MOUNTAIN VIEW CA 94043 |
Gv 2019 Gp, L.p. | 10 percent owner | 1600 AMPHITHEATRE PKWY, MOUNTAIN VIEW CA 94043 |
2021, L.p. Gv | 10 percent owner | 1600 AMPHITHEATRE PARKWAY, MOUNTAIN VIEW CA 94043 |
Gv 2021 Gp, L.l.c. | 10 percent owner | 1600 AMPHITHEATRE PARKWAY, MOUNTAIN VIEW CA 94043 |
Gv 2021 Gp, L.p. | 10 percent owner | 1600 AMPHITHEATRE PARKWAY, MOUNTAIN VIEW CA 94043 |
Thomas Cahill | director | PRIME MEDICINE, INC., 21 ERIE ST., CAMBRIDGE MA 02139 |
Keith Crandell | 10 percent owner | 8755 W. HIGGINS ROAD, SUITE 1025, CHICAGO IL 60631 |
Carman Alenson | officer: See Remarks | 88 SIDNEY STREET, CAMBRIDGE MA 02139 |
Meredith Goldwasser | officer: SVP, Strategy & Corporate Ops. | PRIME MEDICINE, INC., 21 ERIE ST., CAMBRIDGE MA 02139 |
Jeremy Duffield | officer: Chief Scientific Officer | PRIME MEDICINE, INC., 21 ERIE ST., CAMBRIDGE MA 02139 |
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.